Effects of astragaloside IV on inflammation and immunity in rats with experimental periodontitis.
Braz Oral Res. 2019 Apr 25 ;33:e032. Epub 2019 Apr 25. PMID: 31038567
This study aimed to investigate the effects of astragaloside IV (AsIV) on inflammation and immunity in rats with experimental periodontitis. Periodontitis was established in 48 Wistar rats, which were then randomly divided into model and 10, 20 and 40 mg/kg AsIV groups, with 12 rats in each group. The latter 3 groups were treated with AsIV at doses of 10, 20 and 40 mg/kg, respectively. The control group (12 rats, without periodontitis) and model group were given the same amount of 5% sodium carboxymethyl cellulose. The treatment was performed once per day for 8 weeks. Before and after treatment, the tooth mobility scores of the rats were determined. After treatment, the salivary occult blood index (SOBI), plaque index (PLI), peripheral blood T lymphocyte subsets, and serum inflammatory factor and immunoglobulin levels were determined. The results showed that, after treatment, compared with that in model group, in 40 mg/kg AsIV group, the general state of rats was improved, while the tooth mobility score, SOBI and PLI were significantly decreased (p<0.05); the peripheral blood CD4+ T cell percentage and CD4+/CD8+ ratio were significantly increased (p<0.05), while the CD8+ T cell percentage was significantly decreased (p<0.05); the serum tumor necrosis factor-α, interleukin-1β and interleukin-2 levels were significantly decreased (p<0.05); the serum immunoglobulin A and immunoglobulin G levels were significantly decreased (p<0.05). In conclusion, AsIV can alleviate inflammation and enhance immunity in rats with experimental periodontitis.